Portal hypertensive gastropathy with a focus on management

References

• Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013;7(2):141-55
   PubMed Web of Science ®Google Scholar
• Huang YT. Operations for portal hypertension in China. Arch Surg 1985;120(10):1197-9
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002;17(5):526-34
   PubMed Web of Science ®Google Scholar
• Merli M, Nicolini G, Angeloni S, et al. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004;99(10):1959-65
   PubMed Web of Science ®Google Scholar
• Primignani M, Carpinelli L, Preatoni P, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. Gastroenterology 2000;119(1):181-7
   PubMed Web of Science ®Google Scholar
• McCormack TT, Sims J, Eyre-Brook I, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26(11):1226-32
   PubMed Web of Science ®Google Scholar
• Spina G, Arcidiacono R, Bosch J, et al. Gastric endoscopic features in portal hypertension: Final Report of a Consensus Conference, Milan, Italy, September 19, 1992. J Hepatol 1994;21(3):461-7
   PubMed Web of Science ®Google Scholar
• De Franchis R. Updating consensus in portal hypertension: report of the baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33(5):846-52
   PubMed Web of Science ®Google Scholar
• Tanoue K, Hashizume M, Wada H, et al. Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc 1992;38(5):582-5
   PubMed Web of Science ®Google Scholar
• Ohta M, Hashizume M, Higashi H, et al. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994;20(6):1432-6
   PubMed Web of Science ®Google Scholar
• Kumar A, Mishra S, Sharma P, et al. Clinical, laboratory, and Hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. J Clin Gastroenterol 2010;44(4):294-300
   PubMed Web of Science ®Google Scholar
• Curvelo LA, Brabosa W, Rhor R, et al. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach. J Gastroenterol Hepatol 2009;24(9):1541-6
   PubMed Web of Science ®Google Scholar
• Marques C, Mauriz JL, Simonetto D, et al. Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy. Ann Hepatol 2011;10(4):531-9
   PubMed Web of Science ®Google Scholar
• Lan C, Sun X, Dong L, et al. The role of endotoxin in the pathogenesis of gastric mucosal damage in cirrhotic rats with portal hypertensive gastropathy. Asian Pac J Trop Med 2011;4(3):212-14
   Web of Science ®Google Scholar
• Gupta R, Sawant P, Parameshwar RV, et al. Gastric mucosal blood flow and hepatic perfusion index in patients with portal hypertensive gastropathy. J Gastroenterol Hepatol 1998;13(9):921-6
   PubMed Web of Science ®Google Scholar
• Sarin SK, Sreenivas DV, Lahoti D, et al. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992;102(3):994-9
   PubMed Web of Science ®Google Scholar
• Hou MC, Lin HC, Chen CH, et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 1995;42(2):139-44
   PubMed Web of Science ®Google Scholar
• Sarin SK, Shahi HM, Jain M, et al. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 2000;95(10):2888-93
   PubMed Web of Science ®Google Scholar
• Yuksel O, Koklu S, Arhan M, et al. Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study. Dig Dis Sci 2006;51(1):27-30
   PubMed Web of Science ®Google Scholar
• Parikh SS, Desai SB, Prabhu SR, et al. Congestive gastropathy: factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes. Am J Gastroenterol 1994;89(7):1036-42
   PubMed Web of Science ®Google Scholar
• Batmanabane V, Kate V, Ananthakrishnan N. Prevalence of Helicobacter pylori in patients with portal hypertensive gastropathy – a study from south India. Med Sci Monit 2004;10(4):CR133-6
   PubMed Web of Science ®Google Scholar
• Abbas Z, Yakoob J, Usman M, et al. Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and Interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels. Saudi J Gastroenterol 2014;20(2):120-7
   PubMedGoogle Scholar
• Park KS, Kim YH, Choi JS, et al. Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding. Korean J Gastroenterol 2006;47(5):370-8
   PubMedGoogle Scholar
• Perini R, Camara P, Ferraz J. Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice. Nat Clin Pract Gastroenterol Hepatol 2009;6(3):150-8
   PubMedGoogle Scholar
• Trevino H, Brady CIII, Schenker S. Portal Hypertensive Gastropathy. Dig Dis 1996;14(4):258-70
   PubMed Web of Science ®Google Scholar
• Patwardhan VR, Cardenas A. Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. Aliment Pharmacol Ther 2014;40(4):354-62
   PubMed Web of Science ®Google Scholar
• Cubillas R, Rockey DC. Portal hypertensive gastropathy: a review. Liver Int 2010;30(8):1094-102
   PubMed Web of Science ®Google Scholar
• Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric vascular ectasia. Dig Liver Dis 2011;43(5):345-51
   PubMedGoogle Scholar
• Piasecki C, Chin J, Greenslade L, et al. Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut 1995;36(5):654-6
   PubMed Web of Science ®Google Scholar
• El-Newihi H, Kanji V, Mihas A. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroenterol 1996;91(3):535-8
   PubMed Web of Science ®Google Scholar
• Sathar S, Kunnathuparambil S, Sreesh S, et al. Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy. Ann Gastroenterol 2014;27(1):48-52
   PubMedGoogle Scholar
• Payen JL, Cales P, Pienkowski P, et al. Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil. J Hepatol 1995;23(6):689-96
   PubMed Web of Science ®Google Scholar
• Tan S, Wei X, Song M, et al. PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy. Cell Death Dis 2014;5:e1128
   PubMedGoogle Scholar
• Kim JJ, Lee SB, Park JK, et al. TNF-alpha-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-X (L). Cell Death Differ 2010;17(9):1420-34
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46(3):922-38
   PubMed Web of Science ®Google Scholar
• Canlas K, Dobozi B, Lin S, et al. Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia. J Clin Gastroenterol 2008;42(7):844-8
   PubMed Web of Science ®Google Scholar
• Aoyama T, Oka S, Aikata H, et al. Is small-bowel capsule endoscopy effective for diagnosis of esophagogastric lesions related to portal hypertension? J Gastroenterol Hepatol 2013;29(3):511-16
   Web of Science ®Google Scholar
• Berzigotti A, Bosch J. Pharmacologic management of portal hypertension. Clin Liver Dis 2014;18(2):303-17
   PubMed Web of Science ®Google Scholar
• Hosking SW, Kennedy HJ, Seddon I, et al. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987;7(3):437-41
   PubMed Web of Science ®Google Scholar
• Perez-Ayuso R, Pique J, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991;337(8755):1431-4
   PubMed Web of Science ®Google Scholar
• De Franchis R. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53(4):762-8
   PubMed Web of Science ®Google Scholar
• Wagatsuma Y, Naritaka Y, Shimakawa N, et al. Clinical usefulness of the angiotension II receptor antagonist losartan in patients with portal hypertensive gastropathy. Hepatogastroenterology 2006;53(68):171-4
   PubMed Web of Science ®Google Scholar
• Sokol SI, Cheng A, Frishman WH, et al. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure. J Clin Pharmacol 2000;40(1):11-30
   PubMed Web of Science ®Google Scholar
• Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 2012;157(1):49-58
   PubMed Web of Science ®Google Scholar
• British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002;51(Suppl 4):iv1-6
   PubMedGoogle Scholar
• Villanueva C, Colomo A, Bosch A, et al. Transfusion Strategies for Acute Upper Gastrointestinal Bleeding. N Engl J Med 2013;368(1):11-21
   PubMed Web of Science ®Google Scholar
• Duggan J. Review article: transfusion in gastrointestinal haemorrhage – if, when and how much? Aliment Pharmacol Ther 2001;15(8):1109-13
   PubMed Web of Science ®Google Scholar
• Hearnshaw S, Logan R, Palmer K, et al. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010;32(2):215-24
   PubMed Web of Science ®Google Scholar
• Duggan J. Gastrointestinal hemorrhage: should we transfuse less? Dig Dis Sci 2009;54(8):1662-6
   PubMed Web of Science ®Google Scholar
• Razzaghi A, Barkun AN. Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. J Clin Gastroenterol 2012;46(6):482-6
   PubMed Web of Science ®Google Scholar
• Ghassemi S, Garcia-Tsao G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol 2007;21(1):77-93
   PubMed Web of Science ®Google Scholar
• Fernandez J, Ruiz del Arbol L, Gomez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006;131(4):1049-56
   PubMed Web of Science ®Google Scholar
• Valenzuela JE, Schubert T, Fogel MR, et al. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989;10(6):958-61
   PubMed Web of Science ®Google Scholar
• Kouroumalis E, Koutroubakis I, Manousos O. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol 1998;10(6):509-12
   PubMed Web of Science ®Google Scholar
• Zhou Y, Qiao L, Wu J, et al. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: A controlled study. J Gastroenterol Hepatol 2002;17(9):973-9
   PubMed Web of Science ®Google Scholar
• Bruha R, Marecek Z, Spicak J, et al. Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology 2002;49(46):1161-6
   PubMed Web of Science ®Google Scholar
• Cremers M, Oliviera A, Alves A, et al. Portal Hypertensive Gastropathy: Treatment with Corticosteroids. Endoscopy 2002;34(2):177
   PubMed Web of Science ®Google Scholar
• Karajeh M, Hurlstone D, Stephenson T, et al. Refractory bleeding from portal hypertensive gastropathy: a further novel role of thalidomide therapy? Eur J Gastroenterol Hepatol 2006;18(5):545-8
   PubMed Web of Science ®Google Scholar
• Urata J, Yamashita Y, Tsuchigame T, et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol 1998;13(10):1061-7
   PubMed Web of Science ®Google Scholar
• Mezawa S, Homma H, Ohta H, et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 2001;96(4):1155-9
   PubMed Web of Science ®Google Scholar
• Kamath P, Lacerda M, Ahlquist D, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000;118(5):905-11
   PubMed Web of Science ®Google Scholar
• Orloff M, Orloff M, Orloff S, et al. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology 1995;21(4):1011-17
   PubMed Web of Science ®Google Scholar
• Soin A, Acharya S, Mathur M, et al. Portal hypertensive gastropathy in noncirrhotic patients: the effect of lienorenal shunts. J Clin Gastroenterol 1998;26(1):64-7
   PubMed Web of Science ®Google Scholar
• Helton WS, Maves R, Wicks K, et al. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001;136(1):17-20
   PubMed Web of Science ®Google Scholar
• Henderson J, Boyer T, Kutner M, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006;130(6):1643-51
   PubMed Web of Science ®Google Scholar
• Neeff H, Mariaskin D, Spangenberg HC, et al. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg 2011;15(1):1-11
   PubMed Web of Science ®Google Scholar
• Herrera S, Bordas JM, Llach J, et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc 2008;68(3):440-6
   PubMed Web of Science ®Google Scholar
• Smith LA, Morris AJ, Stanley AJ. The use of hemospray in portal hypertensive bleeding; a case series. J Hepatol 2014;60(2):457-60
   PubMed Web of Science ®Google Scholar
• Ali R, Carr-Locke D, Komanduri S, et al. Hemospray for refractory gastrointestinal bleeding: initial united states experience. ACG 2014 Annual Scientific Meeting Abstracts 2014. P1123
   Google Scholar
• Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014;59(3):1144-65
   PubMed Web of Science ®Google Scholar
• Akatsu T, Yoshida M, Kawachi S, et al. Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis. Dig Dis Sci 2006;51(11):2018-22
   PubMed Web of Science ®Google Scholar